证券代码：688079 证券简称：美迪凯 公告编号：2025-007 杭州美迪凯光电科技股份有限公司 第二届监事会第十八次会议决议公告 公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开和出席情况 本议案尚需提交公司 2024 年年度股东大会审议。 （二）审议通过《关于公司 2024 年度财务决算报告的议案》 表决结果：同意 3 票，反对 0 票，弃权 0 票。 杭州美迪凯光电科技股份有限公司（以下简称"公司"）第二届监事会第十 八次会议于 2025 年 4 月 28 日以现场方式召开，会议通知于 2025 年 4 月 18 日以 邮件方式送达全体监事。本次会议应到监事 3 人，实际参加会议 3 人，会议由监 事会主席高志坚主持。会议的召集和召开符合《中华人民共和国公司法》和《公 司章程》的有关规定，会议决议合法有效。 二、监事会会议审议情况 经与会监事审议，一致同意通过如下议案： （一）审议通过《关于监事会 2024 年年度工作报告的议案》 表决结果：同意 3 票，反对 0 票，弃权 0 票。 与会监事听取 ...

杭州美迪凯光电科技股份有限公司 2024 年年度利润分配预案公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●本次不分配利润，不进行资本公积金转增股本。 公司 2024 年度不进行利润分配的原因：2024 年，公司以集中竞价方式回 购股份金额为 5,789,664.80 元（不含印花税、交易佣金等交易费用）。基于公 司 2024 年度业绩亏损、以集中竞价交易方式回购股份的实际情况，综合考量 公司目前经营发展和新项目投入的资金需求，为保持公司稳健发展，更好地维 护全体股东的长远利益，公司 2024 年度利润分配预案为：公司 2024 年度拟不 进行现金分红，不送红股，也不进行资本公积金转增股本。 ●公司 2024 年年度利润分配预案已经公司第二届董事会第二十二次会议和 第二届监事会第十八次会议审议通过，尚需提交公司 2024 年年度股东大会审 议。 ●本次利润分配方案不触及《上海证券交易所科创板股票上市规则（2024 年 4 月修订）》（以下简称《科创板股票上市规则》）第 12.9.1 条第一款第 （八）项 ...

Revenue and Profitability - Revenue for Q1 2025 reached ¥149,496,795.19, an increase of 29.02% compared to ¥115,874,580.90 in the same period last year[4] - Net profit attributable to shareholders was a loss of ¥15,992,072.74, an improvement from a loss of ¥23,558,978.49 year-on-year[4] - Total operating revenue for Q1 2025 reached ¥149,496,795.19, a 29.0% increase from ¥115,874,580.90 in Q1 2024[18] - Net loss for Q1 2025 was ¥16,019,043.08, an improvement from a net loss of ¥24,948,683.53 in Q1 2024[19] - The total comprehensive loss for Q1 2025 was ¥15,967,321.13, an improvement from a loss of ¥24,549,913.32 in Q1 2024[19] - The company reported a basic and diluted earnings per share of -¥0.04 for Q1 2025, compared to -¥0.06 in Q1 2024[19] Cash Flow and Investments - Operating cash flow decreased by 36.76% to ¥15,764,454.78 from ¥24,929,911.36 in the previous year[4] - Cash flow from operating activities generated ¥15,764,454.78 in Q1 2025, down from ¥24,929,911.36 in Q1 2024[21] - Cash flow from investing activities showed a net outflow of ¥90,123,637.57 in Q1 2025, compared to a net outflow of ¥182,875,917.07 in Q1 2024[22] - Cash flow from financing activities generated a net inflow of ¥68,411,055.55 in Q1 2025, down from ¥118,568,697.04 in Q1 2024[22] - The ending cash and cash equivalents balance for Q1 2025 was ¥86,488,506.08, slightly up from ¥85,372,651.19 in Q1 2024[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,050,703,579.19, a slight increase of 0.40% from ¥3,038,469,699.24 at the end of the previous year[5] - The company's current assets decreased to RMB 373,431,863.24 from RMB 412,152,468.02, representing a decline of about 9.4%[13] - The total liabilities increased to RMB 1,660,845,944.59 from RMB 1,641,867,096.02, indicating a rise of approximately 1.3%[15] - The company's cash and cash equivalents decreased significantly from RMB 142,333,629.28 to RMB 87,163,687.70, a drop of around 38.8%[13] - Accounts receivable increased to RMB 105,396,966.50 from RMB 99,383,271.74, showing an increase of about 6.4%[13] - Inventory levels rose slightly to RMB 103,781,021.16 from RMB 101,720,926.68, marking an increase of approximately 2.0%[13] - The company's long-term borrowings decreased to RMB 516,848,520.19 from RMB 531,511,526.05, a reduction of about 2.8%[15] - The total equity attributable to the parent company decreased to RMB 1,352,882,867.74 from RMB 1,359,982,454.52, reflecting a decline of approximately 0.5%[15] - The company's short-term borrowings increased to RMB 267,365,726.45 from RMB 213,935,738.87, an increase of about 25.0%[15] - The company reported a decrease in retained earnings to RMB 62,656,797.85 from RMB 78,648,870.59, a decline of approximately 20.3%[15] Research and Development - R&D investment totaled ¥31,569,364.47, representing 21.12% of revenue, a decrease from 21.85% in the previous year[5] - Research and development expenses increased to ¥31,569,364.47 in Q1 2025, up from ¥25,321,434.65 in Q1 2024[18] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 10,191[10] - The largest shareholder, Hangzhou Meidike Self-owned Capital Investment Partnership, holds 40.61% of the shares[10] Other Financial Highlights - The company reported a non-recurring gain of ¥116,297.52 after tax, primarily from government subsidies and other non-operating income[6] - The increase in revenue was mainly driven by sales growth in optoelectronic and semiconductor packaging products[7] - The weighted average return on equity improved to -1.18% from -1.62% year-on-year[5]

Financial Performance - The net profit attributable to the parent company for 2024 was -101,845,842.42 RMB, while the net profit for the parent company was -4,947,767.23 RMB[5]. - The company plans not to distribute cash dividends, issue bonus shares, or increase capital reserves due to the losses incurred in 2024[5]. - The company is currently not profitable and has not achieved profitability since its listing[3]. - The net profit attributable to shareholders of the listed company was CNY -101.85 million, compared to CNY -84.45 million in 2023[21]. - The net cash flow from operating activities decreased by 40.14% to CNY 76.73 million[21]. - The company reported a basic earnings per share of CNY -0.26 for 2024, compared to CNY -0.21 in 2023[22]. - The company reported a non-recurring loss of approximately ¥8.76 billion in 2024, compared to a loss of ¥9.29 billion in 2023[29]. - The total amount of trading financial liabilities decreased from approximately ¥10.93 million at the beginning of the period to zero at the end of the period[31]. - The company’s cash dividend amount for the last three fiscal years is recorded as 0, indicating no cash dividends were distributed[186]. - The company’s cash buyback amount included in cash dividends for the last fiscal year was 5,789,664.80 RMB[184]. Revenue and Growth - The company achieved operating revenue of CNY 485.51 million in 2024, a year-on-year increase of 51.38%[21]. - The company’s operating revenue for the reporting period was 485.51 million yuan, an increase of 51.38% compared to the same period last year[106]. - Semiconductor optoelectronics revenue grew by 181.45% year-on-year, driven by the mass production of the 12-inch ultrasonic fingerprint recognition chip[110]. - Micro-nano electronics revenue surged by 585.19% year-on-year, mainly due to the ramp-up of production capacity for RF filter chips[112]. - The revenue from semiconductor packaging increased by 194.55% year-on-year, reflecting significant growth in the production of RF chip packaging and ultrasonic fingerprint recognition chip packaging[112]. - The company reported a revenue of 1,182.57 million for the TC-SAW micro circuit technology, with a growth of 349.53% compared to the previous period[84]. Research and Development - The company invested a total of 107.72 million yuan in R&D, accounting for 22.19% of its sales revenue, with 150 dedicated R&D personnel, representing 13.49% of the total workforce[39]. - Cumulative R&D investment over the last three fiscal years amounted to 265,570,166.92 RMB, representing 21.77% of total cumulative revenue[186]. - The company has applied for a total of 354 patents domestically and internationally, with 245 granted and 215 valid patents as of the end of the reporting period[39]. - The company has developed core technologies in precision optics, semiconductor acousto-optics, semiconductor micro-nano circuits (mainly MEMS), semiconductor packaging, and micro-nano optics[75]. - The company is focusing on R&D that aligns with customer needs and market trends, ensuring timely feedback and response[96]. Market and Strategic Focus - The company plans to focus on the optical optoelectronics and semiconductor industries, leveraging existing core technologies and high-quality customer resources to seize opportunities from technological trends such as AI, smart cars, 5G, and the metaverse[144]. - By 2025, the company aims to enhance its business expansion efforts, emphasizing innovation in processes, technology, and management, while developing new technologies, products, and businesses[145]. - The company intends to optimize its product structure and enhance profitability by focusing on differentiated product strategies and expanding its presence in the semiconductor acousto-optics and MEMS markets[146]. - Key investments will be made in semiconductor wafer manufacturing and packaging projects to optimize product structure and enhance core competitiveness[148]. Risk Management - The company has detailed various risks and countermeasures in the report, which can be found in the "Management Discussion and Analysis" section[3]. - The company faces risks related to rapid product technology iteration and potential loss of core personnel[98]. - The company is exposed to macroeconomic risks, including global economic fluctuations and international trade tensions[105]. Corporate Governance and Compliance - The company has established a robust internal control system and governance structure to ensure compliance with relevant laws and regulations, thereby protecting shareholder interests[150]. - The company has implemented key performance indicators across various operational areas to ensure continuous improvement[95]. - The company has no reported risks or dissenting opinions from the Supervisory Board[173]. Employee and Management Structure - The company reported a total of 1,112 employees, with 208 in the parent company and 904 in major subsidiaries[173]. - The company has a structured approach to remuneration that complies with relevant laws and regulations, ensuring no adverse impact on shareholder interests[162]. - The company has implemented a stock option and restricted stock incentive plan for 2024, linking executive performance to company performance[200]. - The total number of shares granted under the 2024 stock option and restricted stock incentive plan represents 2.17% of the total shares outstanding, which is 406,737,698 shares[188]. Future Outlook - The company provided an optimistic outlook for Q4 2023, projecting a revenue growth of 20% compared to Q3 2023[156]. - New product launches are expected to contribute an additional 100 million RMB in revenue in the next quarter[156]. - The management team emphasized a commitment to sustainability, aiming for a 30% reduction in carbon emissions by 2025[156].

证券代码：688079 证券简称：美迪凯 公告编号：2025-006 杭州美迪凯光电科技股份有限公司 关于提请股东大会授权董事会以简易程序向 特定对象发行股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、本次授权事宜概述 根据相关法律法规和规范性文件的规定，杭州美迪凯光电科技股份有限公 司（以下简称"公司"）于 2025 年 4 月 28 日召开第二届董事会第二十二次会 议，审议通过了《关于提请股东大会授权董事会以简易程序向特定对象发行股 票的议案》，同意公司董事会提请股东大会授权董事会决定向特定对象发行融 资总额不超过人民币三亿元且不超过最近一年末净资产百分之二十的股票。授 权期限自 2024 年年度股东大会通过之日起至 2025 年年度股东大会召开之日 止。 本议案尚须提交公司股东大会审议通过。 二、本次授权事宜具体内容 本次授权事宜包括但不限于以下内容： 本次发行股票采用以简易程序向特定对象发行的方式，发行对象为符合中 国证监会规定的证券投资基金管理公司、证券公司、信托公司、财务公司、保 险机构投资者、合格 ...

Financial Performance - The company achieved total operating revenue of 486.59 million yuan in 2024, an increase of 51.72% compared to the previous year[6] - The net profit attributable to the parent company was -98.31 million yuan, a decrease of 13.85 million yuan year-on-year[6] - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) reached 55.19 million yuan, representing a 206.55% increase compared to the previous year[9] - Total assets at the end of the reporting period were 3.04 billion yuan, up 33.45% from the beginning of the period[9] - The company’s total equity attributable to shareholders decreased by 6.79% to 1.36 billion yuan[5] Research and Development - Research and development expenses increased to 107.58 million yuan, up 26.00% year-on-year[8] - The company is gradually ramping up production of new products, including 12-inch ultrasonic fingerprint recognition chips and RF filter chips, contributing to revenue growth[6] Sales and Revenue Growth - The company reported a significant increase in sales revenue from semiconductor optical products, reaching 78.93 million yuan, an increase of 184.00% year-on-year[9] Expenses - The company’s interest expenses rose to 26.08 million yuan, an increase of 276.00% compared to the previous year[8] - The company implemented an equity incentive plan, resulting in an increase in share-based payment expenses by 5.16 million yuan[8]

大股东持股的基本情况 本次减持计划实施前，杭州美迪凯光电科技股份有限公司（以下简称"公司"） 股东香港豐盛佳美（國際）投資有限公司（以下简称"丰盛佳美"）持有公司股 份 36,903,624 股，占公司当时总股本的 9.20%。上述股份来源为公司 IPO 前取 得股份，且已于 2022 年 3 月 2 日解除限售并上市流通。 减持计划的主要内容及实施情况 2024 年 10 月 31 日, 公司披露了《杭州美迪凯光电科技股份有限公司 5%以 上股东减持股份计划公告》（公告编号：2024-057），公司股东丰盛佳美拟自公 告之日起的十五个交易日后三个月内（2024 年 11 月 21 日至 2025 年 2 月 20 日），通过集中竞价和大宗交易方式减持合计不超过 12,039,999 股公司股份， 即不超过公司当时总股本的 3%。其中， 以集中竞价方式减持不超过 4,013,333 股（不超过公司当时股份总数的 1%），以大宗交易方式减持不超过 8,026,666 股（不超过公司当时股份总数的 2%）。 截至本公告披露日，丰盛佳美已通过集中竞价减持股份 4,013,333 股，占公 司当前总股本的 0.986 ...

Financial Projections - The company expects to achieve an operating revenue of approximately 486.87 million yuan in 2024, an increase of about 166.15 million yuan or 51.80% compared to the previous year[2] - The projected net profit attributable to the parent company for 2024 is approximately -98.93 million yuan, with a net profit of -90.07 million yuan after deducting non-recurring gains and losses[2] - EBITDA for 2024 is expected to be around 54.43 million yuan, representing an increase of approximately 36.43 million yuan or 202.34% year-over-year[2] Revenue Breakdown - The revenue from semiconductor acousto-optic products is expected to be around 78.93 million yuan, an increase of approximately 50.88 million yuan compared to the previous year[6] - Revenue from micro-nano electronic products is projected to be about 58.08 million yuan, an increase of approximately 49.60 million yuan year-over-year[6] Expenditure and Costs - The company plans to increase R&D expenditure to approximately 107.58 million yuan in 2024, an increase of about 22.24 million yuan compared to the previous year[7] - Depreciation expenses for 2024 are expected to be around 148.67 million yuan, an increase of approximately 36.62 million yuan year-over-year[7] - Labor costs are projected to rise to approximately 148.45 million yuan in 2024, an increase of about 40.09 million yuan compared to the previous year[7] - Interest expenses are expected to be around 26.62 million yuan in 2024, an increase of approximately 19.73 million yuan year-over-year[7] Equity Incentive Plan - The company has implemented an equity incentive plan, resulting in an increase in share-based payment expenses of approximately 5.16 million yuan[7]

杭州美迪凯光电科技股份有限公司 第七条 公司为永久存续的股份有限公司。 第八条 董事长为公司的法定代表人。 第九条 公司全部资产分为等额股份，股东以其所持股份为限对公司承担责任， 公司以其全部资产对公司的债务承担责任。 第十条 本章程自生效之日起，即成为规范公司的组织与行为、公司与股东、股 东与股东之间权利义务关系的具有法律约束力的文件，对公司、股东、 董事、监事、高级管理人员具有法律约束力的文件。依据本章程，股东 可以起诉股东，股东可以起诉公司董事、监事、总经理和其他高级管理 人员，股东可以起诉公司，公司可以起诉股东、董事、监事、总经理和 其他高级管理人员。 第十一条本章程所称其他高级管理人员是指公司的副总经理、董事会秘书、财务 负责人以及公司董事会认定的公司其他高级管理人员。 第二章 经营宗旨和范围 第三章 股份 章程 二〇二四年十二月 | 第一章 | 总则 1 | | --- | --- | | 第二章 | 经营宗旨和范围 2 | | 第三章 | 股份 2 | | 第一节 | 股份发行 2 | | 第二节 | 股份增减和回购 3 | | 第三节 | 股份转让 4 | | 第四章 | 股东和股东大会 4 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 杭州美迪凯光电科技股份有限公司（以下简称"公司"）于 2024 年 12 月 18 日召开第二届董事会第二十一次会议，审议通过《关于变更注册资本及修改<公司 章程>的议案》。根据公司 2024 年 10 月 14 日召开的 2024 年第一次临时股东大会 审议通过的《关于提请股东大会授权董事会办理公司 2024 年股票期权与限制性股 票激励计划有关事项的议案》，股东大会已同意授权董事会办理本次限制性股票激 励计划的相关事项，因此本次变更注册资本及修改《杭州美迪凯光电科技股份有限 公司章程》（以下简称"《公司章程》"）无需再提交股东大会审议。 证券代码：688079 证券简称：美迪凯 公告编号：2024-066 杭州美迪凯光电科技股份有限公司 关于变更注册资本及修改《公司章程》的公告 除上述条款修改外，《公司章程》其他条款不变。公司将于董事会审议通过 后及时向市场监督管理部门办理变更注册资本及修改《公司章程》的工商备案登 记等相关手续。上述变更最终以市场监督管理部门核准的内容为 ...